2.5302.50% ( -0.065 )
Delay Closed: Nov 17, 16:08:15Valuation
Current ValuationThe current P/E ratio is 28.01, above the reasonable range, cheaper than 4.75% of the time in the past 5 years, and the industry ranks 25/53, the industry Median 6.96.
28.01xP/E
HK$2.53Stock price
HK$0.09Earnings per share
28.01xP/E
Stock priceHK$2.53Earnings per shareHK$0.09
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -3.65x
- Typical range
- -9.05x–-1.02x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.96x
010203040
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.96x
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
03692HKHANSOH PHARMA | 26.36x | 23.06% | HK$202.66B |
03933HKUNITED LAB | 23.29x | 55.30% | HK$14.46B |
09989HKHEPALINK | 26.68x | 18.84% | HK$5.90B |
06996HKANTENGENE-B | 28.01x | 246.19% | HK$1.73B |
03737HKZHONGZHIPHARM | 28.30x | -- | HK$574.29M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
